UBE3A and autism spectrum disorder: In normal cells, the activity of E6AP is tightly controlled, and loss of E6AP expression causes the Angelman syndrome, a neurodevelopmental disorder (Tomaic and Banks, 2015), whereas increased E6AP expression has been associated with autism spectrum disorders (Samaco et al., 2005).